Approval · Notice of Compliance 4563 · 1996
REVEX: Notice of Compliance 4563
Issued November 6, 1996
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4563
- Date
- November 6, 1996
- Company
- Ohmeda Pharmaceutical
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Opioid antagonist
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| REVEX | 02229234 | — |
| REVEX | Not yet assigned | — |
Medicinal ingredients
- NALMEFENE HCL 0.1 MG per ML
- NALMEFENE HCL 1 MG per ML